Implantica receives FDA approval for RefluxStop® - Opening the U.S. market
Go back to Implantica receives FDA approval for RefluxStop® - Opening the U.S. market| Agilent Technologies Inc (NYSE: A) | Delayed: 146.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.85 | 52 Week High | $48.63 | |||
| Open | $146.85 | 52 Week Low | $34.15 | |||
| Day High | $146.85 | P/E | 67.99 | |||
| Day Low | $146.85 | EPS | $2.16 | |||
| Volume | 8 | |||||
| IMPERIAL CAPITAL BANCORP, Inc. (NYSE: IMP) | Delayed: 2.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.42 | 52 Week High | $11.65 | |||
| Open | $2.42 | 52 Week Low | $1.94 | |||
| Day High | $2.42 | P/E | 2.72 | |||
| Day Low | $2.42 | EPS | $0.89 | |||
| Volume | 122,065 | |||||
